KATHRYN SUESS: Open Payments
NPI 1427733658 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$729 in 36 payments from 14 companies in 2025. Trend: 2023 $797 · 2024 $825 · 2025 $729
Food & beverage: $729
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $162 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $87 |
| AstraZeneca Pharmaceuticals LP | 5 | $75 |
| Abbott Laboratories | 4 | $65 |
| Lilly USA, LLC | 4 | $60 |
| ABBVIE INC. | 2 | $47 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| Exact Sciences Corporation | 2 | $44 |
| Astellas Pharma US Inc | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $35 |
Products named: Kerendia, FARXIGA, MOUNJARO, XIFAXAN, Cologuard Collection Kit, Wegovy, FREESTYLE LIBRE 3, Veozah.
Industry payments across AZ — which companies pay providers there.
